Luisa Rios-Avila1, Bonnie Coats2, Yueh-Yun Chi3, Øivind Midttun4, Per M Ueland5, Peter W Stacpoole6, Jesse F Gregory7. 1. Department of Food Science and Human Nutrition. 2. Division of Endocrinology and Metabolism, Department of Medicine, College of Medicine. 3. Department of Biostatistics. 4. Bevital A/S, Laboratoriebygget, Bergen, Norway; and. 5. Department of Clinical Science, University of Bergen, Bergen, Norway. 6. Division of Endocrinology and Metabolism, Department of Medicine, College of Medicine Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, FL. 7. Department of Food Science and Human Nutrition jfgy@ufl.edu.
Abstract
BACKGROUND: The use of oral contraceptives (OCs) has been associated with low plasma pyridoxal 5'-phosphate (PLP). The functional consequences are unclear. OBJECTIVES: To determine whether functional vitamin B-6 insufficiency occurs in OC users and is attributable to OCs, we investigated the associations of PLP with metabolites of one-carbon metabolism, tryptophan catabolism, and inflammation in OC users, and evaluated the effects of OCs on these metabolites. METHODS: Plasma metabolite concentrations were measured in 157 OC users (20-40 y of age). Associations between PLP and the metabolites were analyzed through use of generalized additive models and partial least squares-discriminant analysis (PLS-DA). Additionally, data from 111 of the 157 OC users were compared to previously reported data from 11 nonusers, at adequate and low vitamin B-6 status, with use of multivariate ANOVA. RESULTS: PLP showed significant (P < 0.05) negative nonlinear association with homocysteine, glutathione, and ratios of asymmetric dimethylarginine to arginine, 3-hydroxykynurenine to 3-hydroxyanthranilic acid, and 3-hydroxykynurenine to kynurenic acid. PLS-DA supported these conclusions and identified 3-hydroxykynurenine and the 3-hydroxykynurenine-to-kynurenine ratio as discriminating biomarkers in women with PLP ≤30 nmol/L. Among the many differences, OC users had significantly higher plasma pyridoxal (157% at adequate and 195% at low vitamin B-6 status), 4-pyridoxic acid (154% at adequate and 300% at low vitamin B-6 status), xanthurenic acid (218% at low vitamin B-6 status), 3-hydroxyanthranilic acid (176% at adequate and 166% at low vitamin B-6 status), quinolinic acid (127% at low vitamin B-6 status), and nicotinamide (197% at low vitamin B-6 status). Biomarkers of inflammation were not associated with PLP, and no differences were found between the 2 groups. CONCLUSIONS: PLP is associated with biomarkers of one-carbon metabolism and tryptophan catabolism but not with biomarkers of inflammation in OC users. Independent of vitamin B-6 status, OCs have effects on metabolites and ratios of one-carbon metabolism and tryptophan catabolism but not on biomarkers of inflammation. This study was registered at clinicaltrials.gov as NCT01128244. The study from which data for nonusers was derived was registered as NCT00877812.
BACKGROUND: The use of oral contraceptives (OCs) has been associated with low plasma pyridoxal 5'-phosphate (PLP). The functional consequences are unclear. OBJECTIVES: To determine whether functional vitamin B-6insufficiency occurs in OC users and is attributable to OCs, we investigated the associations of PLP with metabolites of one-carbon metabolism, tryptophan catabolism, and inflammation in OC users, and evaluated the effects of OCs on these metabolites. METHODS: Plasma metabolite concentrations were measured in 157 OC users (20-40 y of age). Associations between PLP and the metabolites were analyzed through use of generalized additive models and partial least squares-discriminant analysis (PLS-DA). Additionally, data from 111 of the 157 OC users were compared to previously reported data from 11 nonusers, at adequate and low vitamin B-6 status, with use of multivariate ANOVA. RESULTS: PLP showed significant (P < 0.05) negative nonlinear association with homocysteine, glutathione, and ratios of asymmetric dimethylarginine to arginine, 3-hydroxykynurenine to 3-hydroxyanthranilic acid, and 3-hydroxykynurenine to kynurenic acid. PLS-DA supported these conclusions and identified 3-hydroxykynurenine and the 3-hydroxykynurenine-to-kynurenine ratio as discriminating biomarkers in women with PLP ≤30 nmol/L. Among the many differences, OC users had significantly higher plasma pyridoxal (157% at adequate and 195% at low vitamin B-6 status), 4-pyridoxic acid (154% at adequate and 300% at low vitamin B-6 status), xanthurenic acid (218% at low vitamin B-6 status), 3-hydroxyanthranilic acid (176% at adequate and 166% at low vitamin B-6 status), quinolinic acid (127% at low vitamin B-6 status), and nicotinamide (197% at low vitamin B-6 status). Biomarkers of inflammation were not associated with PLP, and no differences were found between the 2 groups. CONCLUSIONS: PLP is associated with biomarkers of one-carbon metabolism and tryptophan catabolism but not with biomarkers of inflammation in OC users. Independent of vitamin B-6 status, OCs have effects on metabolites and ratios of one-carbon metabolism and tryptophan catabolism but not on biomarkers of inflammation. This study was registered at clinicaltrials.gov as NCT01128244. The study from which data for nonusers was derived was registered as NCT00877812.
Authors: Carolina P Lima; Steven R Davis; Amy D Mackey; Jennifer B Scheer; Jerry Williamson; Jesse F Gregory Journal: J Nutr Date: 2006-08 Impact factor: 4.798
Authors: K Robinson; K Arheart; H Refsum; L Brattström; G Boers; P Ueland; P Rubba; R Palma-Reis; R Meleady; L Daly; J Witteman; I Graham Journal: Circulation Date: 1998-02-10 Impact factor: 29.690
Authors: Steven R Davis; Jennifer B Scheer; Eoin P Quinlivan; Bonnie S Coats; Peter W Stacpoole; Jesse F Gregory Journal: Am J Clin Nutr Date: 2005-03 Impact factor: 7.045
Authors: R H Böger; S M Bode-Böger; A Szuba; P S Tsao; J R Chan; O Tangphao; T F Blaschke; J P Cooke Journal: Circulation Date: 1998-11-03 Impact factor: 29.690
Authors: Katherine L Tucker; Beth Olson; Peter Bakun; Gerard E Dallal; Jacob Selhub; Irwin H Rosenberg Journal: Am J Clin Nutr Date: 2004-05 Impact factor: 7.045
Authors: Barbara N DeRatt; Maria A Ralat; Vegard Lysne; Fariba Tayyari; Indu Dhar; Arthur S Edison; Timothy J Garrett; Øivind Midttun; Per Magne Ueland; Ottar Kjell Nygård; Jesse F Gregory Journal: J Nutr Date: 2017-08-09 Impact factor: 4.798
Authors: Luisa Rios-Avila; Bonnie Coats; Maria Ralat; Yueh-Yun Chi; Øivind Midttun; Per M Ueland; Peter W Stacpoole; Jesse F Gregory Journal: Am J Clin Nutr Date: 2015-07-22 Impact factor: 7.045
Authors: Toby Candler; Noah J Kessler; Chathura J Gunasekara; Kate A Ward; Philip James; Eleonora Laritsky; Maria S Baker; Roger Dyer; Rajavel Elango; David Jeffries; Robert A Waterland; Sophie E Moore; Marian Ludgate; Andrew M Prentice; Matt J Silver Journal: Sci Adv Date: 2021-11-05 Impact factor: 14.136